Rinvatercept
Rinvatercept, a fusion protein, is a glycyl (1) -chimeric N-terminal (1-108) -peptide (2-109) combined from the sequences of the extracellular domains of the human ACVR2A/B, and is fused via a G3 peptide linker (110-112) to an immunoglobulin G1 (IgG1) Fc fragment. Rinvatercept can be used for research of neuromuscular disease[1].
Product Specifications
CAS Number
2996105-98-5
UNSPSC
12352203
Target
TGF-β Receptor
Related Pathways
TGF-beta/Smad
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Smiles
[Rinvatercept]
References & Citations
[1]International Nonproprietary Names for Pharmaceutical. WHO Drug Information, Vol. 38 , No. 4, 2024.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
